Saturday, December 23, 2006

Veridex Receives FDA Approval for Breast Cancer Test Kit

Research and diagnostic technology company Immunicon on Friday announced that Johnson & Johnson subsidiary Veridex has received FDA approval to market its CellSearch Circulating Tumor Cell Kit, the Philadelphia Inquirer reports. CellSearch is aimed at earlier detection of metastatic breast cancer that has spread to other parts of the body, according to the Inquirer. CellSearch uses blood samples to identify and count tumor cells in the body (Loyd, Philadelphia Inquirer, 12/15). Immunicon has an agreement with Veridex to sell the test .--Click the title of this post to read the full article from its source--

Labels: , , , ,


Post a Comment

<< Home

/* WebRing Code */